Enliven Therapeutics Cash Flow Statement (2019-2026) | ELVN

Cash Flow Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-13.91M-14.38M-8.90M-9.46M-11.20M-29.71M-16.44M-20.25M-24.67M-65.52M-26.07M-24.92M-27.15M-26.94M-31.78M-29.20M-25.61M-34.40M-27.93M-39.12M
Depreciation and Depletion (Quarter)
0.02M0.03M0.04M0.40M0.06M0.06M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.08M0.07M0.08M0.06M0.05M0.01M0.01M
Share-based Compensation (Quarter)
1.00M0.98M0.65M0.70M1.10M2.80M2.26M4.20M3.40M3.06M4.51M5.14M5.18M5.34M6.80M7.72M1.30M12.31M7.40M13.91M
Deferred Taxes (Quarter)
Cash from Operations (Quarter)
-10.90M-12.48M-10.36M-7.12M-6.45M-8.14M-20.84M-12.05M-15.89M-12.48M-23.36M-20.43M-12.19M-17.20M-24.13M-17.06M-13.28M-15.84M-19.29M-18.53M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.02M-0.05M-0.05M0.05M0.83M1.98M1.79M0.66M0.60M-0.71M-0.98M0.04M-0.07M0.31M-0.06M-0.27M-0.51M
Depreciation & Amortization (CF) (Quarter)
0.02M0.03M39.00M0.05M0.06M0.05M0.07M0.07M0.08M0.08M0.08M0.08M0.08M0.06M0.07M0.08M0.06M0.08M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
-0.15M-0.12M-1.56M0.59M1.36M0.02M0.49M-0.19M-1.59M-0.96M2.15M-1.60M-0.06M0.32M0.22M0.79M-1.02M0.83M-0.52M-1.50M
Change in Accured Expenses (Quarter)
0.43M0.16M-0.29M0.85M0.39M0.66M-2.85M1.10M4.64M4.78M-3.06M-0.25M4.35M-1.28M-2.50M0.01M0.81M1.18M-4.46M3.19M
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)
0.19M0.30M0.01M0.10M0.03M0.09M0.02M0.01M0.02M0.00M0.02M0.02M0.14M-0.00M0.10M
Change in Acquisitions & Divestments (Quarter)
13.40M3.30M5.47M6.48M-11.95M40.00M80.00M38.91M77.17M80.59M117.24M60.67M56.74M67.80M87.69M108.36M118.69M
Cash from Investing Activities (Quarter)
-8.83M-14.49M-0.19M-0.30M-0.01M-0.10M-0.03M-151.52M-35.55M38.69M-17.89M-33.66M14.83M0.73M1.43M-183.59M-4.06M12.38M42.53M-441.57M
Financing Activities
Other financing activities (Quarter)
0.14M0.57M0.01M0.01M0.14M0.14M0.03M0.09M0.27M1.79M1.12M0.45M0.23M1.32M0.21M0.53M10.05M29.59M
Cash from Financing Activities (Quarter)
46.99M-0.01M0.41M0.01M0.16M-2.38M237.44M-2.82M-0.42M0.09M90.27M1.81M1.12M39.97M0.23M218.38M-0.37M0.62M10.05M463.42M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
162.90M-1.53M
Additional items
Change in Cash (Quarter)
27.26M-26.99M-10.15M-7.42M-6.30M-10.62M216.57M-166.39M-51.87M26.29M49.02M-52.29M3.75M23.50M-22.47M17.73M-17.70M-2.84M33.29M3.32M
Free Cash Flow (Quarter)
-10.90M-12.48M-10.55M-7.43M-6.46M-8.25M-20.88M-12.14M-15.91M-12.50M-23.38M-20.44M-12.21M-17.20M-24.15M-17.20M-13.28M-15.84M-19.29M-18.63M
Net Cash Flow (Quarter)
27.26M-26.99M-10.15M-7.42M-6.30M-10.62M216.57M-166.39M-51.87M26.29M49.02M-52.29M3.75M23.50M-22.47M17.73M-17.70M-2.84M33.29M3.32M